Hope to Start Supply of ZyCoV-D Covid-19 Vaccine by Mid to End Sept: Zydus Group MD

The company's indigenously developed needle-free three-dose Covid-19 vaccine ZyCoVD was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country

from Top Business News- News18.com